GEN Exclusives

More »

GEN News Highlights

More »
Oct 25, 2006

Laureate Pharma Will Continue to Manufacture Cytogen’s ProstaScint

  • Laureate Pharma renewed its agreement with Cytogen for the cGMP manufacture of ProstaScint®, Cytogen's Mab immunoconjugate that is used for imaging in patients diagnosed with prostate cancer.

    Under the agreement, Laureate will provide cGMP protein production and purification, conjugation of Cytogen's linker chelator, and aseptic filling services to support Cytogen's commercial ProstaScint requirements.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?